US watchdog finds gaps in Medicare fraud risk assessments covering $481 billion in benefits
A November 18 federal audit says Medicare's fraud-risk process overlooks important vulnerabilities, prompting recommendations to improve how risks are identified and assessed.
A new US Government Accountability Office report has identified shortcomings in how federal health officials assess fraud risks in traditional Medicare, raising questions about whether preventive safeguards cover the programme's full range of vulnerabilities.
The November 18 audit examined the Centers for Medicare & Medicaid Services and its Center for Program Integrity, which oversees fraud prevention in Medicare Fee-for-Service. According to the GAO, CMS reported spending nearly $481 billion on benefits for approximately 34 million beneficiaries in 2025.
The watchdog found that the centre's existing Vulnerability Management Process is broader than a structured fraud-risk assessment and does not consistently identify or evaluate the full set of fraud risks. GAO said its review of inspector-general reports revealed risks that had not been identified or assessed through the process.
One concern involved enrolment screening for suppliers of medical equipment. The audit said potential ways to circumvent screening were not adequately assessed as fraud risks. The finding describes a control weakness, not a determination that every supplier or payment is fraudulent.
GAO compared the agency's practices with its Fraud Risk Framework, which calls for identifying risks, evaluating their likelihood and consequences, and assessing whether controls are sufficient. It concluded that the existing process leaves opportunities to address risks before losses occur.
Independent coverage by Medicaid Monitor also described the gap between the current process and the structured framework, including the absence of consistent likelihood and impact assessments.
The audit recommends improvements to risk identification and evaluation. Its conclusions concern the design of oversight, rather than a quantified estimate of fraud actually committed. The public-interest question is whether the agency can document a more systematic approach to preventing misuse of Medicare funds.
Spotted an error? Request a correction · Our editorial principles · Contact the newsroom